0000874015-24-000224.txt : 20241001 0000874015-24-000224.hdr.sgml : 20241001 20241001180146 ACCESSION NUMBER: 0000874015-24-000224 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240929 FILED AS OF DATE: 20241001 DATE AS OF CHANGE: 20241001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Devers Shannon L. CENTRAL INDEX KEY: 0002037721 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 241344667 MAIL ADDRESS: STREET 1: C/O IONIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 3 1 edgardoc.xml PRIMARY DOCUMENT X0206 3 2024-09-29 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0002037721 Devers Shannon L. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP, Chief Human Resourses Ofc Common Stock 7909 D Non-Qualified Stock Option (right to buy) 32.6 2023-01-03 2032-01-02 Common Stock 14368 D Non-Qualified Stock Option (right to buy) 37.58 2024-01-03 2033-01-02 Common Stock 15317 D Non-Qualified Stock Option (right to buy) 48.51 2021-04-05 2027-04-04 Common Stock 6000 D Non-Qualified Stock Option (right to buy) 49.25 2019-01-02 2025-01-01 Common Stock 16042 D Non-Qualified Stock Option (right to buy) 52.87 2020-01-02 2034-01-01 Common Stock 18526 D Non-Qualified Stock Option (right to buy) 53.77 2020-01-02 2026-01-01 Common Stock 16777 D Non-Qualified Stock Option (right to buy) 56.78 2022-01-04 2028-01-03 Common Stock 28516 D Non-Qualified Stock Option (right to buy) 60.89 2021-01-02 2027-01-01 Common Stock 17125 D Restricted Stock Unit 0.0 Common Stock 31241 D Each restricted stock unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Grants to reporting person of restricted stock units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan on January 15, 2021, January 15, 2022, January 15, 2023 and January 15, 2024. The restricted stock units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. By: Patrick R. O'Neil, attorney-in-fact For: Shannon L. Devers 2024-10-01